Phase 1 Tirbanibulin Ointment DNA synthesis inhibitor trial for keratinocyte carcinomas

This trial evaluates fractional laser therapy alone versus in combination with tirbanibulin ointment for treating squamous and basal cell carcinomas. Eligible first-line patients with superficial to invasive keratinocyte carcinomas are enrolled to assess if the combined approach can minimize invasive surgery and improve cosmetic outcomes at a New York site sponsored by Bruce Robinson, MD.